Agilent Technologies Inc vs iShares MSCI France ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares MSCI France ETF trades at $47.71. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares MSCI France ETF pays none. Which is the better fit depends on your goals.
| A | EWQ | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $48.35 |
52-Week Low | $110.24 | $41.68 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
EWQ, the iShares MSCI France ETF, trades at $47.9, up 0.63% in the past 24 hours, with a bullish technical signal from moving averages but bearish oscillators. The ETF is concentrated in industrials and benefits from French economic initiatives like tech sovereignty funding. A dividend of $1.09 is scheduled for June 2026, adding income appeal.
The outlook is positive due to attractive valuations and European market momentum, but risks include ECB policy shifts and geopolitical tensions affecting energy prices. Investors may find opportunity in France's growth-focused policies, though sensitivity to regional volatility warrants caution.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →